department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Covid-19 Vaccine · pharmadog

pharmadog
drugs
Covid-19 Vaccine

drug

patient view →

Coronavirus Disease 2019 (COVID-19) vaccine 1

Marketedupdated 2mo ago

by $NVAX NOVAVAX INC

Approved

community read0 votes

Vaccine component drug with a maximum clinical stage of Approval, with an approval for covid-19.

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Covid-19 Vaccine

generic

mivalsecovatein [INN]

MOA

Spike glycoprotein vaccine antigen

indication

Coronavirus Disease 2019 (COVID-19)

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 54m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 6

tagCardiology2 co-mentions · 1 sources
drugCoronavirus Disease 2019 (COVID-19) vaccine1 co-mentions · 1 sources
drugUndisclosed1 co-mentions · 1 sources
drugundisclosed Covid-19 vaccine1 co-mentions · 1 sources
companyBarts Charity1 co-mentions · 1 sources
tagVaccine1 co-mentions · 1 sources

Trials studying Coronavirus Disease 2019 (COVID-19) vaccine 1

EP1Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mixactive not recruitingn=20
—A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenzaactive not recruitingn=999
phase1A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adultsrecruitingn=225
phase4Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19active not recruitingn=285,000
phase2Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.completedn=887
phase1Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19recruitingn=20
phase2SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Canceractive not recruitingn=63
phase4The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infectioncompletedn=1,188

more trials →